Cargando…
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
The recent outbreak of Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) infection has led to more than 800 laboratory-confirmed MERS cases with a high case fatality rate (∼35%), posing a serious threat to global public health and calling for the development of effective and safe therap...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114414/ https://www.ncbi.nlm.nih.gov/pubmed/25451066 http://dx.doi.org/10.1016/j.virusres.2014.10.007 |